A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors

NCT00879905 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies

Interventions

DRUG: HSP990

Sponsor

Novartis Pharmaceuticals